Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol versus propofol for cardiovascular events during urologic surgery under general anesthesia
ChiCTR2300072767Phase 4Completed
- Sponsor
- Renmin Hospital of Wuhan University
- Start
- Jun 2022
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofol and propofol in genitourinary diseases (GU) (2 arms), sponsored by Renmin Hospital of Wuhan University. Primary endpoints: Vital signs and Electrocardiogram changes. Started Jun 2022; status: completed.
02
Drugs
ciprofolpropofol
03
Conditions
genitourinary diseases (GU)
Beyond the preview
Go deeper on ChiCTR2300072767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072767.